Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,397,678
+$732,518 QoQ
Shares Held
21,450
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1,260
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Southeast Asset Advisors, LLC holds $26,273,942 across 7 Drug Manufacturers - General names. ABBV ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
45,781 | $11,627,000 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
21,450 | $5,397,678 | |
| 3 | LLY |
ELI LILLY & Co
|
2,848 | $3,415,976 | |
| 4 | PFE |
Pfizer Inc
|
99,468 | $2,395,189 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,706 | $1,632,721 | |
| 6 | NVS |
Novartis AG
|
6,716 | $1,052,531 | |
| 7 | AMGN |
Amgen Inc
|
2,079 | $752,847 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,397,678 | 21,450 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,665,160 | 21,450 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,187,408 | 22,703 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,860,508 | 25,311 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,882,492 | 15,529 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,210,265 | 15,322 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,307,079 | 12,983 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,645,639 | 13,397 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,297,681 | 13,396 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,439,047 | 13,394 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,137,501 | 13,793 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,017,079 | 13,532 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,647,747 | 12,230 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,948,935 | 12,229 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,551,294 | 9,599 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,473,894 | 10,982 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,936,095 | 12,641 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,071,603 | 12,779 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,662,305 | 12,277 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,321,299 | 12,249 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,167,738 | 10,367 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $277,367 | 2,563 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $227,050 | 2,119 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||